← All trials
NCT05818124
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 21, 2023
- Primary completion
- Mar 29, 2024
- Completion date
- Mar 29, 2024
- First posted
- Apr 18, 2023
- Last posted
- Aug 30, 2023
- Enrollment
- 160
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.